GE Healthcare:企業のM&A・事業提携・投資動向

◆英語タイトル:GE Healthcare - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2069
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:450
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

GE Healthcare – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s GE Healthcare Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by GE Healthcare since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes GE Healthcare’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by GE Healthcare. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on GE Healthcare’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by GE Healthcare and its subsidiaries since 2007.
- Information about key financial and legal advisors for GE Healthcare’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about GE Healthcare’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
CORPORATE VENTURING 77
Corporate Venturing – Deal reports 77
PARTNERSHIP 86
Partnership – Overview 86
Partnership – Deal reports 87
DIVESTMENTS 409
Divestments – Overview 409
Divestments – Deal reports 410
APPENDIX 440
Contact Us 440
About MarketLine Financial Deals Database 440
Deal Definition and Methodology 442
About MarketLine 449

List of Tables
Table 1: GE Healthcare M&A volume and value trend (2014-YTD2018)
Table 2: GE Healthcare M&A activity by geography (2014-YTD2018)
Table 3: GE Healthcare partnership volume and value trend (2014-YTD2018)
Table 4: GE Healthcare partnership trend by key deal type (2014-YTD2018)
Table 5: GE Healthcare divestments volume and value trend (2014-YTD2018)
Table 6: GE Healthcare divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: GE Healthcare M&A volume and value trend (2014-YTD2018)
Figure 2: GE Healthcare M&A activity by geography (2014-YTD2018)
Figure 3: GE Healthcare partnership volume and value trend (2014-YTD2018)
Figure 4: GE Healthcare partnership trend by key deal type (2014-YTD2018)
Figure 5: GE Healthcare divestments volume and value trend (2014-YTD2018)
Figure 6: GE Healthcare divestments by geography (2014-YTD2018)

★海外企業調査レポート[GE Healthcare:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Magnitogorsk Iron & Steel Works:企業の戦略・SWOT・財務情報
    Magnitogorsk Iron & Steel Works - Strategy, SWOT and Corporate Finance Report Summary Magnitogorsk Iron & Steel Works - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Chesapeake Energy Corporation (CHK)-石油・ガス分野:企業M&A・提携分析
    Summary Chesapeake Energy Corporation (Chesapeake) is an upstream oil and gas company. The company explores develops and produces oil and gas from its assets. It has liquid operations in Eagle Ford Shale; the Utica Shale; the Granite Wash, Cleveland, Tonkawa and Mississippian Lime plays in the Anada …
  • Grupo TMM SAB:企業の戦略・SWOT・財務分析
    Grupo TMM SAB - Strategy, SWOT and Corporate Finance Report Summary Grupo TMM SAB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Boral Limited:企業のM&A・事業提携・投資動向
    Boral Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Boral Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • SK Innovation Co Ltd (096770):石油・ガス:M&Aディール及び事業提携情報
    Summary SK Innovation Co Ltd (SK Innovation) is an integrated energy and petrochemical company. It explores for and produces crude oil and natural gas; transportation of crude oil; and production of oil products such as gasoline and diesel. Through subsidiaries, the company carries out refining oper …
  • Knopp Biosciences LLC-製薬・医療分野:企業M&A・提携分析
    Summary Knopp Biosciences LLC (Knopp Biosciences) is a drug discovery and development company that develops and markets medicines for the treatment of neurological disorders. The company's lead product candidate, dexpramipexole, is an orally bioavailable small molecule which is used for the treatmen …
  • Broadridge Financial Solutions Inc (BR):企業の財務・戦略的SWOT分析
    Broadridge Financial Solutions Inc (BR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Cooper Tire & Rubber Co (CTB):企業の財務・戦略的SWOT分析
    Cooper Tire & Rubber Co (CTB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Vexim SA (ALVXM):企業の財務・戦略的SWOT分析
    Summary Vexim SA (Vexim), a subsidiary of Stryker Corp, is a healthcare product manufacturer that provides solutions for patients suffering from vertebral compression fractures. The company provides solutions such as controlled anatomical restoration and advanced vertebroplasty therapy. Its controll …
  • Cesca Therapeutics Inc (KOOL):企業の財務・戦略的SWOT分析
    Cesca Therapeutics Inc (KOOL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • National Bank of Greece SA:企業のM&A・事業提携・投資動向
    National Bank of Greece SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's National Bank of Greece SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • PAREXEL International Corporation:企業の戦略・SWOT・財務分析
    PAREXEL International Corporation - Strategy, SWOT and Corporate Finance Report Summary PAREXEL International Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Parker Hannifin Corporation (PH)-医療機器分野:企業M&A・提携分析
    Summary Parker Hannifin Corporation (Parker) is a manufacturer of motion and control technologies and systems. The company offers critical motion and control solutions including fluid power systems, electromechanical controls and related components. Its products find use in various industries and ap …
  • Tohoku Electric Power Co Inc:発電所・企業SWOT分析
    Tohoku Electric Power Co Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • General Re Corporation:企業の戦略・SWOT・財務情報
    General Re Corporation - Strategy, SWOT and Corporate Finance Report Summary General Re Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Acasti Pharma Inc (APO):企業の財務・戦略的SWOT分析
    Summary Acasti Pharma Inc (Acasti), a subsidiary of Neptune Technologies & Bioressources Inc, is a biopharmaceutical company that conducts research, development, and commercialization of krill oil-based forms of omega-3 fatty acids. The company develops phospholipid therapies for abnormalities in bl …
  • Hilton Worldwide Holdings Inc:戦略・SWOT・企業財務分析
    Hilton Worldwide Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Hilton Worldwide Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • XERIS Pharmaceuticals Inc (XERS):製薬・医療:M&Aディール及び事業提携情報
    Summary XERIS Pharmaceuticals Inc (XERIS) is a specialty pharmaceutical company that develops and commercializes injectable and infusible drug formulations. The company’s proprietary XeriSol and XeriJect formulation technologies allow for the subcutaneous and intramuscular delivery of ultra concentr …
  • AS Eesti Gaas:企業の戦略的SWOT分析
    AS Eesti Gaas - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Petronet LNG Ltd (PETRONET):石油・ガス:M&Aディール及び事業提携情報
    Summary Petronet LNG Ltd (Petronet) is an energy company with operations in the midstream sector. The company was formed as a joint venture by the Government of India to import liquefied natural gas (LNG) and set up LNG terminals in the country. Its major promoters include GAIL (India) Ltd, Oil & Na …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆